Imidazole → [(4-Cyclopropyloct-1-yn-4-yl)oxy](trimethyl)silane
Reaction equation
[CH:1]1([C:4]([OH:12])([CH2:8][CH2:9][CH2:10][CH3:11])[CH2:5][C:6]#[CH:7])[CH2:3][CH2:2]1.N1C=CN=C1.Cl[Si:19]([CH3:22])([CH3:21])[CH3:20]>CN(C)C=O>[CH:1]1([C:4]([O:12][Si:19]([CH3:22])([CH3:21])[CH3:20])([CH2:8][CH2:9][CH2:10][CH3:11])[CH2:5][C:6]#[CH:7])[CH2:2][CH2:3]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of 27.8 g. of 4-cyclopropyl-4-hydroxy-1-octyne (Example 9) and 33.3 g. of imidazole in 130 ml of dimethylformamide at 5° C. is added 24 ml. of chlorotrimethylsilane during 5 minutes. The solution is stirred at ambient temperature for 17 hours and then partitioned with 600 ml of hexane and 250 ml of ice-water. The hexane phase is separated and washed successively with water and brine. The solution is dried over magnesium sulfate and evaporated to give a liquid, p.m.r. spectrum (C D Cl3): δ0.12 (singlet, trimethylsiloxy group), 2.02 (triplet, HC≡C), and 2.45 (doublet, C≡CH2).
Workup
- custompartitioned with 600 ml of hexane and 250 ml of ice-water
- customThe hexane phase is separated
- washwashed successively with water and brine
- dry with materialThe solution is dried over magnesium sulfate
- customevaporated
- customto give a liquid, p.m.r
Sources & evidence
- ORD record
- ord-ca72667d943a4ffcb16f0fef87607202
- Source dataset
- uspto-grants-1978_12
- Patent number
- US04131737
Reaction notes
Loading…